BioElectronics Corporation announced that it has appointed Evomed as the distributor for ActiPatch® Musculoskeletal Pain Relief Therapy, Allay® Menstrual Pain Relief Therapy and Smart Insole Heel Pain Relief Therapy in Australia and New Zealand. Evomed will also be promoting the ActiPatch 7-Day Trial Device to assist chronic pain sufferers with an affordable way to trial the device.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -33.33% |
|
0.00% | -50.00% |
03-25 | BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study | CI |
02-23 | Bioelectronics Corporation Announces the Publication of Pilot Study Results | CI |
1st Jan change | Capi. | |
---|---|---|
-50.00% | 2.47M | |
+7.23% | 217B | |
+11.31% | 191B | |
+28.94% | 154B | |
+32.00% | 112B | |
-0.46% | 62.84B | |
+16.09% | 53.34B | |
+0.94% | 48.83B | |
-2.97% | 39.36B | |
+1.23% | 35.73B |
- Stock Market
- Equities
- BIEL Stock
- News BioElectronics Corporation
- BioElectronics Corporation Appoints Evomed as Australian and New Zealand Distributor